Dive into Neurology with Brain Games: March 30, 2025!

Are you ready to test your knowledge in the fascinating world of neurology? Welcome to NeurologyLive® Brain Games! This exciting weekly quiz, airing every Sunday morning, challenges you with intriguing questions that span both clinical practices and the rich history of neurology. Crafted by a team of seasoned physicians, clinicians, and neurological care experts, this series promises to stimulate your mind and expand your understanding of neurological conditions.

Each week, you'll encounter three thought-provoking questions that dive into crucial areas of neurology. This week, we shine a spotlight on CGRP (Calcitonin Gene-Related Peptide) medications, which are making waves in the treatment of migraines. Prepare to explore a range of disorders, including dementia, Alzheimer’s disease, epilepsy, migraines, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and the perplexing field of cerebrovascular diseases.

Here’s what you’ll face in today's quiz:

1. **Primary Mechanism of Action**: Which of the following is the primary mechanism of action of CGRP antagonists used in the treatment of migraine? - A) Inhibition of prostaglandin production - B) Blockage of CGRP receptors - C) Activation of serotonin receptors - D) Inhibition of nitric oxide production

2. **Common Side Effects**: What is a common side effect associated with the use of CGRP inhibitors? - A) Bradycardia - B) Dizziness - C) Constipation - D) Hypertension

3. **FDA Approval**: Which of the following CGRP inhibitors is FDA-approved for both preventive and acute treatment of migraines? - A) Erenumab - B) Ubrogepant - C) Rimegepant - D) Fremanezumab

Put your neurology knowledge to the test and see how you stack up against other participants! Not only can you learn about these groundbreaking therapies, but you can also engage in a fun and interactive way to better understand neurological disorders.

Feeling inspired? If you have insightful quiz questions you'd like to share, don’t hesitate to reach out to our editor at his email address: mmeglio@neurologylive.com. Your contributions could help shape future quizzes.

Join us every week for more enlightening challenges and to expand your horizons in neurology—because every question could unlock a new understanding!